We are live on ! Find out more
Jim Simons

Jim Simons Renaissance Technologies

AUM $63.9B
1-Year Est. Return 45.56%
 

Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.

This Fund
S&P 500
This Quarter Est. Return
+2.28%
1 Year Est. Return
+45.56%
3 Year Est. Return
+129.95%
5 Year Est. Return
+153.6%
10 Year Est. Return
+738.31%
AUM
$38.1B
AUM Growth
Cap. Flow
+$38.4B
Cap. Flow %
100.8%
Top 10 Hldgs %
11.4%
Holding
2,756
New
2,750
Increased
Reduced
Closed

Top Buys

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$671M
2
MCD icon
McDonald's
MCD
+$636M
3
TSM icon
TSMC
TSM
+$515M
4
NVO
Novo Nordisk
NVO
+$465M
5
CL icon
Colgate-Palmolive
CL
+$458M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Technology 14.45%
2 Healthcare 11.94%
3 Consumer Discretionary 11.58%
4 Consumer Staples 10.68%
5 Financials 9.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NTES icon
26
NetEase
NTES
$81.9B
$180M 0.47%
+14,277,000
New +$167M
C icon
27
Citigroup
C
$228B
$177M 0.46%
+3,696,420
New +$178M
PNRA
28
DELISTED
Panera Bread Co
PNRA
$175M 0.46%
+939,992
New +$172M
GEN icon
29
Gen Digital
GEN
$17.4B
$167M 0.44%
+7,443,338
New +$175M
TWTC
30
DELISTED
TW TELECOM INC CL A COM
TWTC
$166M 0.44%
+5,902,500
New +$163M
DPZ icon
31
Domino's
DPZ
$11.8B
$164M 0.43%
+2,828,300
New +$158M
LO
32
DELISTED
LORILLARD INC COM STK
LO
$163M 0.43%
+3,729,300
New +$160M
AZN icon
33
AstraZeneca
AZN
$246B
$162M 0.42%
+3,425,700
New +$174M
SHW icon
34
Sherwin-Williams
SHW
$88.5B
$161M 0.42%
+2,739,600
New +$165M
VRSK icon
35
Verisk Analytics
VRSK
$23.6B
$158M 0.41%
+2,641,300
New +$158M
RYN icon
36
Rayonier
RYN
$6.45B
$156M 0.41%
+4,158,300
New +$161M
PHI icon
37
PLDT
PHI
$4.23B
$148M 0.39%
+2,175,900
New +$155M
PETM
38
DELISTED
PETSMART INC
PETM
$144M 0.38%
+2,156,593
New +$145M
RYAAY icon
39
Ryanair
RYAAY
$30.8B
$141M 0.37%
+6,676,556
New +$126M
SLB icon
40
SLB Ltd
SLB
$79.7B
$141M 0.37%
+1,963,893
New +$145M
MPC icon
41
Marathon Petroleum
MPC
$94.5B
$138M 0.36%
+3,886,600
New +$155M
AZO icon
42
AutoZone
AZO
$49.7B
$134M 0.35%
+315,100
New +$129M
HD icon
43
Home Depot
HD
$353B
$129M 0.34%
+1,665,300
New +$125M
STX icon
44
Seagate
STX
$186B
$129M 0.34%
+2,871,400
New +$116M
AMGN icon
45
Amgen
AMGN
$224B
$126M 0.33%
+1,274,945
New +$132M
ABV
46
DELISTED
COMPANHIA BEBIDA ADS EACH REPSTG 1 PFD SH
ABV
$124M 0.33%
+3,329,700
New +$132M
CPB icon
47
Campbell Soup
CPB
$6.78B
$123M 0.32%
+2,751,200
New +$125M
CYBX
48
DELISTED
CYBERONICS INC
CYBX
$121M 0.32%
+2,325,394
New +$110M
ALGT icon
49
Allegiant Air
ALGT
$2.37B
$119M 0.31%
+1,127,300
New +$106M
ISRG icon
50
Intuitive Surgical
ISRG
$142B
$117M 0.31%
+2,077,830
New +$114M

Similar funds

Jim Simons's Q2 2013 Portfolio in Review

Q2 2013 is the first quarter with a 13F filing on record for Jim Simons, which disclosed 2,756 positions worth $38.1B. Its ten largest holdings account for 11% of the portfolio.

Its largest position is Eli Lilly: 12,326,205 shares worth $605M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, followed by Healthcare and Consumer Discretionary.

  • Jim Simons's largest Q2 2013 buy was Eli Lilly: 12,326,205 shares worth $605M.
  • Jim Simons's ten largest holdings make up 11% of its $38.1B portfolio in Q2 2013.
  • Jim Simons disclosed 2,756 positions in Q2 2013, its first 13F filing on record.

Based on Renaissance Technologies's 13F filing for Q2 2013, filed 12 Aug 2013.